Compound class
Healing peptides
Short peptides, listed with what FDA documents say about human data.
Most compounds here are short peptides: TB-500 is a seven-amino-acid fragment of thymosin beta-4,1 thymosin alpha-1 has 28 amino acids,2 and KPV is a tripeptide.3 FDA's briefing documents found no human pharmacokinetic data for BPC-157 after oral, subcutaneous, nasal or transdermal use; in two rectal enema studies that measured plasma levels, BPC-157 was reported as not detected, or mostly below the lower limit of quantification.4 The same documents found no human pharmacokinetic or pharmacodynamic studies of TB-500,1 and no clinical studies of KPV in humans.3 Thymosin alpha-1 differs, as the same FDA document calls Zadaxin a finished drug product available in other countries.2
Compounds in this class 17
-
KLOW
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
BPC-157 + TB-500
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
BPC-157
Gastric peptide
- Half-life
- Not stated
- Given
- Once daily as a rectal enema in studies
- Form or status
- No product label among its sources
-
Glutathione
Tripeptide
- Half-life
- 14.1 minutes after IV infusion
- Given
- Once daily by mouth in studies
- Form or status
- Italian label for Tationil injection
-
KPV
Melanocortin fragment
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
ARA-290 (Cibinetide)
Tissue-Protective peptide
- Half-life
- About 2 minutes (review); about 20 minutes after a dose under the skin
- Given
- Three times weekly IV in one sarcoidosis trial
- Form or status
- No product label among its sources
-
B7-33
Relaxin analog
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Cartalax
Peptide bioregulator
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Epithalon
Synthetic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
FOXO4-DRI
Senolytic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
GLOW
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
LL-37
Cathelicidin peptide
- Half-life
- Not stated
- Given
- Twice weekly as a cream on foot ulcers (one trial)
- Form or status
- No product label among its sources
-
TB-500
Thymic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Thymalin
Thymic peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Thymosin Alpha-1
Thymic peptide
- Half-life
- About 2 hours
- Given
- Not stated
- Form or status
- No product label among its sources
-
Vilon
Peptide bioregulator
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
VIP (Vasoactive Intestinal Peptide)
Vasoactive peptide
- Half-life
- About one minute after IV infusion
- Given
- Three times daily, inhaled, in one registered study
- Form or status
- Labelled only as part of a combination product (Invicorp)
Half-lives side by side
The figure each source gives, on one scale. Bars are ranges.
- ARA-290 (Cibinetide)about 2 min, review
- Glutathione14.1 min, IV
- Thymosin Alpha-1about 2 h
Log scale, 1 minute to about 3 weeks. Each figure and its source are in the list above. Minutes, days and weeks are turned into hours (1 day is 24 hours) only to place them on the scale. These are the sources' figures; the half-life the app uses to draw levels can differ.
Where some figures in the list come from
- Glutathione: Tationil, the Italian injection behind its status, is labelled for preventing nerve damage from chemotherapy with cisplatin or similar drugs.5
Guides 15
- B7-33 dosage: mixing and syringe unitsNo label or human trial gives a B7-33 dose. Mouse study doses, the parent hormone's trial, and why no vial strength or syringe mark can be sourced.
- BPC-157 and TB-500: blend or two vials, and unitsHow BPC-157 and TB-500 are sold as a blend or two vials, how a mix converts to syringe units, and the dose, schedule and storage figures sources give.
- BPC-157 dosage: mixing a 10 mg vial and unitsWhat a review, FDA's briefing and the registered human studies give for BPC-157 dose and schedule, with a 10 mg vial mixing table and syringe marks.
- Cartalax dosage: mixing and syringe unitsSearches found no label or human trial with a cartalax dose. What sources say, the 20 mg powder one vendor sells, and why no syringe mark can be sourced.
- Epitalon dosage: reported doses and vial arithmeticEpitalon doses reported in a narrative review and on websites cited by FDA, plus syringe arithmetic only, and the storage figures each source reports.
- GLOW peptide dosage: blend contents and logged vial setupsGLOW vial contents, doses logged in Milligram, a 70 mg vial example, and separate trials of BPC-157 and of thymosin beta 4 itself, not TB-500.
- Glutathione dosage by injection: label and logged vialsThe Italian 600 mg glutathione injection label and trials, plus syringe arithmetic for the 1,500 mg vial setups logged in Milligram, and FDA warnings.
- How to mix KLOW: the 80 mg vial and syringe unitsHow an 80 mg KLOW vial mixes with 2 or 3 mL of water, what the 4 mg dose people most often log reads on a U-100 syringe, and what sources say.
- How to mix thymosin alpha-1: vials and syringe unitsThe Zadaxin label copy mixes a 1.6 mg vial with 1 mL of sterile water (1.6 mg/mL). Label and trial doses, the syringe mark and storage figures.
- KPV dosage: mixing a 10 mg vial and unitsFDA found no human KPV study and DailyMed no KPV label. What users log, how a 10 mg vial maps to U-100 syringe units, and FDA's storage figures.
- LL-37 dosage: mixing and syringe unitsLL-37 trial doses and schedules arm by arm, FDA's compounding position, and the vial and syringe arithmetic for a powder in mg.
- TB-500 dosage: what a dental case report and FDA sayNo TB-500 label or human trial dose turned up. A 3-patient dental case report gave 10 mg weekly inside the mouth for 4 weeks, with other agents.
- Thymalin dosage: mixing and syringe unitsWhat the Russian thymalin label and a COVID-19 trial state about dose, diluent, cycle length and storage, with syringe marks for the label's vial.
- Vilon dosage: mixing and syringe unitsWhat the evidence gives for Vilon dose: no label found, one vendor strength of 20 mg, and three trial summaries that state no dose or schedule.
- VIP dosage: aviptadil evidence by routeVIP and aviptadil doses from one injection label and inhaled and IV trials; a small human nasal study gave no dose, and none gives nasal-spray mixing.
Calculators 11
- ARA-290 dosage calculator: vials, water and unitsUnits on a U-100 syringe for ARA-290 (Cibinetide): enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- BPC-157 reconstitution calculator: 5 and 10 mg vialsUnits on a U-100 syringe for BPC-157: enter your vial, water and dose, or print the chart for 5, 10 and 20 mg vials.
- BPC-157 TB-500 reconstitution calculatorUnits on a U-100 syringe for BPC-157 + TB-500: enter your vial, water and dose, or print the chart for 10 and 20 mg vials.
- Epitalon dosage calculator and reconstitutionUnits on a U-100 syringe for epithalon: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- FOXO4-DRI dosage calculator: vials, water and unitsUnits on a U-100 syringe for FOXO4-DRI: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- GLOW dosage calculator: vials, water and unitsUnits on a U-100 syringe for GLOW: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Glutathione reconstitution calculator: 1,500 mg vialUnits on a U-100 syringe for glutathione: enter your vial, water and dose, or print the chart for 600 and 1,500 mg vials.
- KLOW calculator: vials, water and unitsUnits on a U-100 syringe for KLOW: enter your vial, water and dose, or print the chart for 80 mg vials. Starts at the setup Milligram users log most.
- KPV dosage calculator: vials, water and unitsUnits on a U-100 syringe for KPV: enter your vial, water and dose, or print the chart for 10 mg vials. Starts at the setup Milligram users log most.
- TB-500 dosage calculator: 5 and 10 mg vialsUnits on a U-100 syringe for TB-500: enter your vial, water and dose, or print the chart for 5 and 10 mg vials.
- Thymosin alpha-1 dosage calculator: vials, water and unitsUnits on a U-100 syringe for thymosin alpha-1: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
Logged in Milligram
Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.
KLOW, how often
BPC-157 + TB-500, how often
BPC-157, how often
Glutathione, how often
KPV, how often
How often: among people with three or more logged doses, by the average gap between their doses.
Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.
References 14
- Mathew B, Mattingly A, Rupp T, Albuquerque E, Benedict A, Kneeream E, Kasim S (US Food and Drug Administration). July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee - FDA Briefing Document for TB-500-Related Bulk Drug Substances (TB-500 (free base) and TB-500 acetate). FDA 2026. fda.gov
- U.S. Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee, December 4, 2024: thymosin alpha-1-related bulk drug substances. 2024. fda.gov
- US Food and Drug Administration. July 23-24, 2026, Meeting of the Pharmacy Compounding Advisory Committee: FDA Briefing Document for KPV-Related Bulk Drug Substances (KPV (Free Base) and KPV Acetate). 2026. fda.gov
- US Food and Drug Administration. FDA Briefing Document Pharmacy Compounding Advisory Committee (PCAC) Meeting July 23 - 24, 2026. 2026. fda.gov
- Teofarma. Tationil (glutathione) 600 mg powder and solvent for solution for injection. Italian summary of product characteristics (riassunto delle caratteristiche del prodotto), text revised June 2010. Tationil product information
- Aebi S, Assereto R, Lauterburg BH. High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest 1991. PMID 1907548
- Sarkar R, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol 2025. PMID 39444151
- Collino M, Thiemermann C, Cerami A, Brines M. Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. Pharmacol Ther 2015. PMID 25728128
- Brines M, Dunne AN, van Velzen M, et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med 2015. PMID 25387363
- Heij L, Niesters M, Swartjes M, et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med 2012. PMID 23168581
- Miranda E, Bramono K, Yunir E, et al. Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial. Arch Dermatol Res 2023. PMC10514151
- Domschke S, et al. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects. Gut 1978;19(11):1049-53. PMID 730072
- ClinicalTrials.gov. NCT04536350: Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS. NCT04536350
- Invicorp 25 micrograms/2 mg solution for injection (aviptadil and phentolamine mesilate). Evolan Pharma AB. Swedish summary of product characteristics (produktresumé), revised 2026. Invicorp product information
Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.